Ernst Moritz Arndt University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Greifswald Germany (1933)

Organization Overview

First Clinical Trial
2003
NCT00196417
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Department of Clinical Pharmacology, Ernst-Moritz-Arndt-University Greifswald | Department of Gastroenterology, Endocrinology and Nutrition, Ernst-Moritz-Arndt University Greifswald | Ernst-Moritz-Arndt University Greifswald, Germany | Institute for Immunology and Transfusion Medicine, Ernst-Moritz-Arndt-University Greifswald | Medical Faculty, Ernst-Moritz-Arndt University Greifswald | Pediatric Department, Ernst-Moritz-Arndt-University Greifswald | University Hospital of Ernst-Moritz-Arndt-University Greifswald

Active Ingredients

Drugs in Phase 4 Trials (1)

heparin (liquaemin) (2 trials)

Drugs in Phase 3 Trials (5)

beta carotene (solatene) (1 trial)

magnesium oxide (1 trial)

selenium (1 trial)

vitamin c (1 trial)

vitamin e (1 trial)

Drugs in Phase 2 Trials (1)

oleogel-s10 (1 trial)

Drugs in Phase 1 Trials (1)

propranolol (inderal) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hemorrhage (Phase 4)

Pancreatitis (Phase 3)

Thrombocytopenia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 8